TY - JOUR T1 - Prospective validation of smartphone-based heart rate and respiratory rate measurement algorithms JF - medRxiv DO - 10.1101/2021.03.08.21252408 SP - 2021.03.08.21252408 AU - Sean Bae AU - Silviu Borac AU - Yunus Emre AU - Jonathan Wang AU - Jiang Wu AU - Mehr Kashyap AU - Si-Hyuck Kang AU - Liwen Chen AU - Melissa Moran AU - John Cannon AU - Eric S. Teasley AU - Allen Chai AU - Yun Liu AU - Neal Wadhwa AU - Mike Krainin AU - Michael Rubinstein AU - Alejandra Maciel AU - Michael V. McConnell AU - Shwetak Patel AU - Greg S. Corrado AU - James A. Taylor AU - Jiening Zhan AU - Ming Jack Po Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/03/12/2021.03.08.21252408.abstract N2 - Measuring vital signs plays a key role in both patient care and wellness, but can be challenging outside of medical settings due to the lack of specialized equipment. In this study, we prospectively evaluated smartphone camera-based techniques for measuring heart rate (HR) and respiratory rate (RR) for consumer wellness use. HR was measured by placing the finger over the rear-facing camera, while RR was measured via a video of the participants sitting still in front of the front-facing camera. In the HR study of 95 participants (with a protocol that included both measurements at rest and post exercise), the mean absolute percent error (MAPE) ± standard deviation of the measurement was 1.6% ± 4.3%, which was significantly lower than the pre-specified goal of 5%. No significant differences in the MAPE were present across colorimeter-measured skin-tone subgroups: 1.8% ± 4.5% for very light to intermediate, 1.3% ± 3.3% for tan and brown, and 1.8% ± 4.9% for dark. In the RR study of 50 participants, the mean absolute error (MAE) was 0.78 ± 0.61 breaths/min, which was significantly lower than the pre-specified goal of 3 breath/min. The MAE was low in both healthy participants (0.70 ± 0.67 breaths/min), and participants with chronic respiratory conditions (0.80 ± 0.60 breaths/min). Our results validate that smartphone camera-based techniques can accurately measure HR and RR across a range of pre-defined subgroups.Competing Interest StatementAll authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf and declare: all authors are employees of Google LLC except M.Kashyap and J.C. who are paid consultant of Google via Advanced Clinical; Google LLC may commercialize this technology or have patent rights now or in the future related to this paper. All the authors except M.Kashyap, S.K., and J.C. own Alphabet stock. M.J.P. is a member of the board of El Camino Health, advisory committee of ONC Interoperability Task Force, and scientific advisory board of National Library of Medicine, NIH.Clinical TrialThis work was validation studies of a smartphone application for consumer wellness use.Funding StatementThis study was supported by Google Health. Google Health was involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The HR and RR study protocols were approved by Advarra IRB (Columbia, MD; protocol no. Pro00046845) and Aspire IRB (now WCG IRB, Puyallup, WA; protocol no. 20201594), respectively.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesParticipants of this study did not consent to public sharing of their data, so the raw data are not available. ER -